Trellis Bioscience
Redwood City, US · Delaware corporation · 3 known investors
Biotech
Founders & leadership
SR
Stefan RyserPresident and Chief Executive Officer
GD
Geoff DillonChief Business Officer
LK
Larry KauvarChief Science Officer
EW
Elisabeth WhitneyChief Operating Officer
NM
Nora MendeChief Financial Officer
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$6.1MraisedMay 2026 · 16 investors · BiotechnologyRule 506(b)
▶$6.1MraisedMay 2026 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stefan RyserExecutive Officer
- Geoff DillonExecutive Officer
- Larry KauvarExecutive Officer
- Elisabeth WhitneyExecutive Officer
- Nora MendeExecutive Officer
- Amount sold
- $6.1M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- The $9M push to crack prosthetic joint infections - Becker’s Spine Reviewbeckersspine.com · 2026
- Trellis Bioscience Raises $9 Million Series C To Advance Calpurbatug For Prosthetic Joint Infectionspulse2.com · 2026
- Trellis Bioscience Raises $9M in Series C Fundingfinsmes.com · 2026
- Trellis Bioscience Raises $9 Million to Advance Phase 2 Trial of Biofilm-Targeting Therapy for Prosthetic Joint Infections | citybizcitybiz.co · 2026
